Article

Challenges and Lessons Learned from COVID-19 Trials – Should We be Doing Clinical Trials Differently?

2021-03-04

Abstract excerpt

The COVID-19 crisis led to a flurry of clinical trials activity. The COVID-Evidence database shows 2,814 COVID-19 randomized trials registered as of February 16, 2021. Most were small (only 18% have a planned sample size >500) and the rare completed ones have not provided published results promptly (only 283 trial publications as of 2/2021). Small randomized trials and observational, non-randomized analyses have n...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 548c33b6-312f-5972-aeb9-bdb067fbfdb9
DOI: 10.2139/ssrn.3797780

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Challenges and Lessons Learned from COVID-19 Trials – Should We be Doing Clinical Trials Differently?DOI 10.2139/ssrn.3797780Read

Global landscape of randomized controlled trials responding to the COVID-19 pandemic: a literature review protocolSemantic proximity Read

The Current Landscape of Clinical TrialsSemantic proximity Read

A snapshot of the ongoing clinical research on COVID-19Semantic proximity Read

Baseline results of a living systematic review for COVID-19 clinical trial registrationsSemantic proximity Read

COVID-19: Why SOLIDARITY and DisCoVeRy trials may fail to bring informative and timely resultsSemantic proximity Read

Outcomes evaluated in controlled clinical trials on the management of COVID-19: A methodological systematic reviewSemantic proximity Read

How the clinical research community responded to the COVID-19 pandemic: An analysis of the COVID-19 clinical studies in ClinicalTrials.govSemantic proximity Read

regCOVID: Tracking publications of registered COVID-19 studiesSemantic proximity Read

The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions.Semantic proximity Read

Impact of the COVID-19 Pandemic on Clinical Trial Conduct: Lessons for the FutureSemantic proximity Read

Characteristics of Registered Systematic Reviews on Treatment for COVID-19 in Prospero PlatformSemantic proximity Read

Vitamin D, acute respiratory infections, and Covid-19: the curse of small-size randomised trials. A critical review with meta-analysis of randomised trialsSemantic proximity Read